Attached files

file filename
10-K - Emergent BioSolutions Inc.form10-k.htm
EX-23.1 - Emergent BioSolutions Inc.ex23_1.htm
EX-31.2 - Emergent BioSolutions Inc.ex31_2.htm
EX-32.1 - Emergent BioSolutions Inc.ex32_1.htm
EX-31.1 - Emergent BioSolutions Inc.ex31_1.htm
EX-10.7 - Emergent BioSolutions Inc.ex10_7.htm
EX-10.6 - Emergent BioSolutions Inc.ex10_6.htm
EX-21.1 - Emergent BioSolutions Inc.ex21_1.htm
EX-10.21 - Emergent BioSolutions Inc.ex10_21.htm
EX-10.41 - Emergent BioSolutions Inc.ex10_41.htm
EX-10.20 - Emergent BioSolutions Inc.ex10_20.htm
EX-10.18 - Emergent BioSolutions Inc.ex10_18.htm
EX-10.19 - Emergent BioSolutions Inc.ex10_19.htm
EX-10.26 - Emergent BioSolutions Inc.ex10_26.htm
EX-10.40 - Emergent BioSolutions Inc.ex10_40.htm
EX-10.22 - Emergent BioSolutions Inc.ex10_22.htm



 
Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
 
AS ADOPTED PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report on Form 10-K of Emergent BioSolutions Inc. (the "Company") for the year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Fuad El-Hibri, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: March 5, 2010
/s/ R. Don Elsey
R. Don Elsey
Chief Financial Officer